ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2697

Modulator Role of Inducible Costimulator (ICOS) in Spondyloarthritis Animal Model

Luiza Krause1, Quentin Jouhault2, Bilade Cherqaoui1, Aude Jobart-Malfait1, Ignacio Anegon3, Gilles Chiocchia4 and Maxime A. Breban5, 1INSERM-U1173, University of Versailles Saint-Quentin-en-Yvelines, France, Montigny-le-Bretonneux, France, 2Infection and inflammation, INSERM-U1173, University of Versailles Saint-Quentin-en-Yvelines, France, Montigny-le-Bretonneux, France, 3U643, INSERM-UMR643- Nantes-CHU, Nantes, France, 4Infection and Inflammation, INSERM-U1173, University of Versailles Saint-Quentin-en-Yvelines, France, Montigny-le-Bretonneux, France, 5Rheumatology, Ambroise Paré Hospital, and Versailles Saint Quentin en Yvelines University, Boulogne-Billancourt, France

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: animal models and spondylarthritis, T cells

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  HLA-B27/hβ2m transgenic rats (B27 rats), a model of spondylarthritis (SpA) develop spontaneous colitis and arthritis. Recently, in vitro studies demonstrated that altered dendritic cells (DCs) function promoted a biased expansion of pro-inflammatory Th17 cells and alterations of regulatory CD4+ T cells (Treg) function, characterized by heightened IL-17 and decreased Il-10 production. Interestingly, in vitro blockade of ICOS-ICOSL interaction reversed IL-10/IL-17 imbalanced production by Treg. These data led us to investigate the in vivo consequences of ICOS/ICOSL interaction in experimental SpA using a genetic approach by producing B27 rats with Icos deletion (B27.ICOS-/- rats).

Methods:  ICOS-/- rats were produced using TALEN technology, and backcrossed onto the B27 transgenic background (F344). B27.ICOS+/+ and B27.ICOS-/- rats were weekly weighted, examined and scored for clinical symptoms (colitis, arthritis, alopecia and orchitis). Inflammatory pattern was determined by histological analysis and ex-vivo production of pro-inflammatory cytokines.

Results:  As expected, chronic diarrhea was the most common manifestation, starting at 9 weeks of age in all B27.ICOS+/+ rats. Arthritis and alopecia developed only in some B27.ICOS+/+ rats. The clinical score progressively worsened in B27.ICOS+/+ rats. In contrast, the B27-ICOS-/- rats did not develop any symptom of disease until age of 16 weeks and attenuated symptoms were observed until 24 weeks, a finding that was confirmed by histopathology analysis. Decreased in vitro production of pro-inflammatory cytokines and increased IL-10 production by CD4+ T cells were consistently observed in the B27-ICOS-/- rats.

Conclusion:  Those results indicate a protective effect of Icos deletion on the onset and severity of SpA in the B27 rat. The protective effect was associated to a decrease of pro-inflammatory T cells and an increased proportion of IL-10-producing CD4+T cells. Those data corroborate previous observation suggesting a key role for ICOS signaling in the imbalanced production of IL-10 and IL-17 by Treg in the B27 rat and highlight ICOS as a putative therapeutic target in SpA.


Disclosure: L. Krause, None; Q. Jouhault, None; B. Cherqaoui, None; A. Jobart-Malfait, None; I. Anegon, None; G. Chiocchia, None; M. A. Breban, None.

To cite this abstract in AMA style:

Krause L, Jouhault Q, Cherqaoui B, Jobart-Malfait A, Anegon I, Chiocchia G, Breban MA. Modulator Role of Inducible Costimulator (ICOS) in Spondyloarthritis Animal Model [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/modulator-role-of-inducible-costimulator-icos-in-spondyloarthritis-animal-model/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/modulator-role-of-inducible-costimulator-icos-in-spondyloarthritis-animal-model/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology